Product Information
BUFFERED ASPIRIN 325 MG TB is a generic product labeled by Cardinal Health, priced at $0.0207 per EA under NDC 70000014701. Its NADAC has been published 392 times since Dec 26, 2018.
Strength
325 mg/1
Manufacturer
Cardinal HealthNDC
70000014701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ASPIRINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
3/30/1990
Pharmacological Classes
Price Statistics
The NADAC for BUFFERED ASPIRIN 325 MG TB has been published 392 times since Dec 26, 2018, and over the history we have for it it has risen 11.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0207 per EA |
|---|---|
| All-time high | $0.0220 (Aug 14, 2024) |
| All-time low | $0.0176 (Apr 22, 2020) |
| 52-week high | $0.0207 |
| 52-week low | $0.0198 |
| Median price | $0.0192 |
| Average price | $0.0194 |
| Largest weekly change | +17.7% (Jan 19, 2022) |
| Weeks tracked | 392 |
| Tracking since | Dec 26, 2018 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUFFERED ASPIRIN 325 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for BUFFERED ASPIRIN 325 MG TB, manufactured by Cardinal Health, is $0.0207 per EA (NDC 70000014701), effective Jun 24, 2026.
How has the price of BUFFERED ASPIRIN 325 MG TB changed over time?
Over the history we have for it, the NADAC for BUFFERED ASPIRIN 325 MG TB has risen 11.8%. It has been tracked across 392 weekly CMS publications since Dec 26, 2018.
What are the highest and lowest recorded NADAC prices for BUFFERED ASPIRIN 325 MG TB?
Since Dec 26, 2018, the NADAC for BUFFERED ASPIRIN 325 MG TB has ranged from a low of $0.0176 (Apr 22, 2020) to a high of $0.0220 (Aug 14, 2024), with a median of $0.0192 per EA.
Are there cheaper alternatives to BUFFERED ASPIRIN 325 MG TB?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QC ASPIRIN 325 MG TABLET, is $0.0121 per EA — about 42% below BUFFERED ASPIRIN 325 MG TB.
Who manufactures BUFFERED ASPIRIN 325 MG TB?
BUFFERED ASPIRIN 325 MG TB (NDC 70000014701) is labeled by Cardinal Health, and CMS classifies it as a generic product.
Related Drugs
Same classification